| abstract |
Provision of a novel combined therapy with ECyd, which therapy exhibits remarkable antitumor effect and gives less adverse effects. n The invention provides an antitumor agent containing, in combination, 1-(3-C-ethynyl-β-D-ribopentofuranosyl)cytosine or a salt thereof and carboplatin. |